LIPOMATOUS HYPERTROPHY OF THE INTERATRIAL SEPTUM

This adverse event was reported 7 times

These drugs are most commonly taken by patients reporting LIPOMATOUS HYPERTROPHY OF THE INTERATRIAL SEPTUM:

# Drug Count
0 PREDNISONE 3
1 SIMVASTATIN 2
2 0XYGEN 1
3 ACETAMINOPHEN 1
4 ACETAMINOPHEN 500MG 1
5 ACETAMINOPHEN TABLET EXTENDED RELEASE 1
6 ADALIMUMAB 1
7 ALBUTEROL 1
8 ALBUTEROL SULFATE 1
9 ALPRAZOLAM 1
See all common drugs associated with LIPOMATOUS HYPERTROPHY OF THE INTERATRIAL SEPTUM

LIPOMATOUS HYPERTROPHY OF THE INTERATRIAL SEPTUM is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Insulin [EPC] 1 0.0000
1 Tetracycline-class Drug [EPC] 1 0.0000
2 Cardiac Glycoside [EPC] 1 0.0000
3 Nitrate Vasodilator [EPC] 1 0.0000
4 Serotonin Reuptake Inhibitor [EPC] 1 0.0000
5 Antirheumatic Agent [EPC] 1 0.0000
6 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
7 Calcium [EPC] 1 0.0000
8 Azole Antifungal [EPC] 1 0.0000
9 HMG-CoA Reductase Inhibitor [EPC] 2 0.0000
See all drug classes enriched for association with LIPOMATOUS HYPERTROPHY OF THE INTERATRIAL SEPTUM